Catalyst Management Team
M. Douglas Winship
Vice President of Regulatory Operations
M. Douglas Winship joined Catalyst in July 2006 as its Vice President of Regulatory Operations. Mr. Winship has worked in regulatory affairs and clinical operations in the healthcare industry for more than 35 years. From 2004 to 2005, Mr. Winship was Vice President–Quality Assurance and Regulatory Affairs for Argos Therapeutics, Inc., a biotechnology company developing immunotherapy treatments for cancer, in Durham, North Carolina. Previously, Mr. Winship was employed by CEL-SCI Corp., a biotechnology company developing immune system based treatments, in Vienna, Virginia, from 1998 to 2002 as Senior Vice President–Regulatory Affairs and Quality Assurance, and from 1994 through 1998 as Vice President–Regulatory Affairs and Quality Assurance. From 1988 to 1994, Mr. Winship was employed by Curative Technologies, Inc. (now Wound Care Centers, Inc.), a health-care company involved in the wound-healing market, first as Director of Regulatory Affairs and Quality Assurance and later as Vice President of Regulatory Affairs and Quality Assurance. Mr. Winship earned his bachelor of science degree in chemistry from Upsala College in 1971.
Management
- Patrick J. McEnany – Co-Founder, Chairman, President and Chief Executive Officer
- Charles W. Gorodetzky, MD, PhD – Chief Medical Officer
- Alicia Grande, CPA, CMA – Corporate Controller and Chief Accounting Officer
- Steven R. Miller, PhD – Chief Scientific Officer
- Jack Weinstein – Chief Financial Officer, Treasurer, and Vice President, Business Development
- M. Douglas Winship – Vice President of Regulatory Operations
